Feb. 6 at 3:14 PM
$CMPS pardon, honest question here, no position in Compass, no interest in shorting, etc.
From what I understand, with the recent refusal on COMP360 voucher, there's some discussion as to "its okay, because they already have FDA fasttrack, the voucher was redundant". Which is true, makes sense to me.
But if thats the case, then why apply for the voucher in the first place? Can anyone shed some light on that for me?
Is this a valid signal from the administration? Is it just sortve bungling the bureaucratic process? (which is fair, talk about complex). Whats the scoop here? ...sorry if this is already discussed ad nauseum, but I prefer fishing over hunting.
